Walleye Capital LLC Ptc Therapeutics, Inc. Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $1.81 Million - $2.95 Million	73,484 Added 630.06%	85,147 $2.6 Million
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $281,661 - $372,632	11,663 New	11,663 $339,000
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $1.46 Million - $2.74 Million	65,226 Added 958.64%	72,030 $1.61 Million
Q2 2023 Aug 14, 2023	SELL	$40.4 - $59.1 $3.11 Million - $4.55 Million	-76,942 Reduced 91.88%	6,804 $276,000
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $438,267 - $561,157	-11,485 Reduced 12.06%	83,746 $4.06 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $3.19 Million - $5.22 Million	95,231 New	95,231 $3.63 Million
Q2 2022 Aug 08, 2022	BUY	$25.6 - $45.23 $1.29 Million - $2.28 Million	50,379 Added 502.13%	60,412 $2.42 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $334,399 - $447,471	10,033 New	10,033 $374,000
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $48,554 - $89,040	-1,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $6,637 - $10,314	206 Added 15.92%	1,500 $72,000
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $45,833 - $58,230	1,294 New	1,294 $58,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.